AKR1A1 and ovarian carcinoma: It was discovered that upregulated mRNA of the AKR1C1–4 enzymes (originally known as dihydrodiol dehydrogenases) and AKR1A1 induces a resistance to cisplatin in human ovarian cancer cells [53].